NLC Health Ventures is a venture builder based in The Netherlands and active worldwide, with a portfolio of 70+ startups. Three of them are exhibiting: IPD (NL) has a unique technology to treat prosthetic and metal implant infections in the human body, Garland Surgical (UK) offers a novel prosthesis and technique that addresses the challenge of hip replacement surgeries and Amotio (UK) has designed a patient specific surgical device to accurately and rapidly remove bone cement without trauma.
Heron Therapeutics, Inc.
Our mission is to improve the lives of patients by developing novel, best-in-class treatments to address some of the most important unmet patient needs. We aim to develop patient-focused solutions by applying our innovative science and technologies with well-known pharmacology. | Heron’s mission is to improve patient’s lives by developing best-in-class medicines that address major unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents.
Hans Biomed USA, Inc.
HansBiomed USA is a leading bio-engineering company that manufactures different types of orthobiologics such as DBM and allograft. HansBiomed has the largest bio-engineering research institute in Asia and have received 510(k) approval for DBM products. As the first tissue bank established in Korea, HansBiomed has been developing a variety of biologic products
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is a top-biotech joint venture specializing in the research, development, manufacture and marketing of medical device and pharmaceuticals based on gene engineering and biochemical technology since 1993. Our core product is Bone Repair Materials, applicable for bone defect, nonunion treatment as well as oral and spinal procedures. It achieves an annual global sales volume of USD115 million, delivering reliable clinical solutions.
Emergent CRO
Emergent CRO is a MedTech-focused clinical research organization supporting orthopedic, spine, and sports medicine innovators from first-in-human through post-market. We deliver senior-level oversight, agile execution, and transparent pricing. Acting as an extension of your team, we integrate seamlessly to design smarter studies, activate the right sites, and keep trials moving forward. We don’t just manage studies, we become true partners in your success. Built to Care. Built for MedTech!
EMD Serono
EMD Serono, the healthcare business sector of Merck KGaA, Darmstadt, Germany, in the US and Canada, is a science-led organization dedicated to making a meaningful difference in the lives of people affected by cancer. Our oncology research aims to leverage our synergistic portfolio to tackle challenging tumor types, as we work to illuminate a path to scientific breakthroughs to transform patient outcomes. Learn more at www.emdseronooncology.com | We are the healthcare business in the U.S.A. & Canada for Merck KGaA, Darmstadt, Germany, a vibrant science and technology company. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. The passion of our curious minds makes a positive difference to millions of people’s lives every day. In Healthcare, we discover unique ways to treat the most challenging diseases, such as multiple sclerosis and cancer. Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information. Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live. We are curious minds dedicated to human progress. | In Healthcare, we are at the forefront of developing pioneering therapies – boldly aiming to meaningfully change the lives of patients, their families, and their caregivers. We are unlocking leaps in highly specialized fields with significant unmet medical needs. We leverage internal discoveries and external partnerships to serve patients who need it most across all continents. As one company, science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. The passion of our curious minds makes a positive difference to millions of people’s lives every day. Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information. Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live. We are sparking discovery, elevating humanity. | We are the healthcare business in the U.S.A. & Canada for Merck KGaA, Darmstadt, Germany, a vibrant science and technology company. EMD Serono Aspires to create, improve and prolong lives — As One for Patients. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. The passion of our curious minds makes a positive difference to millions of people’s lives every day. In Healthcare, we discover unique ways to treat the most challenging diseases, such as multiple sclerosis and cancer. Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information. Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live. We are curious minds dedicated to human progress.
Elsevier
As a global leader in information and analytics, we help researchers and healthcare professionals to advance science and improve health outcomes, striving to create a better future for everyone. We offer evidence-based information and advanced AI solutions to support the work of the research and healthcare communities worldwide. | A global leader in advanced information and decision support, Elsevier helps to advance science and healthcare, to advance human progress. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies. | Elsevier Health applies innovation, facilitates insights, and helps drive more informed decision-making for students, clinicians, leaders, educators and policymakers, across healthcare systems globally. We support health providers by supplying accessible, trusted evidence-based information to take on the infodemic; preparing more future health professionals; improving patient outcomes; delivering truly inclusive healthcare; and supporting personalized and localized care experiences. Together, we aim to empower healthcare professionals to provide optimal care that improves outcomes for all patients. | A global leader in advanced information and decision support, Elsevier helps to advance science and healthcare, to advance human progress. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies. We have supported the work of our research and healthcare communities for more than 140 years. Our 9,700 employees around the world, including 2,300 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 3,000 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray’s Anatomy. Together with the Elsevier Foundation, we work in partnership with the communities we serve to advance inclusion in science, research and healthcare in developing countries and around the world. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com. | For more than 140 years, Elsevier has helped advance science and human progress. We’ve evolved to a global leader in seamlessly integrating trusted content, technology and scientific expertise to support research and development. Discover, innovate and develop with confidence supported by a portfolio of connected, configurable solutions for R&D. | Elsevier, a global leader in information and analytics, helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. Growing from our roots in publishing, we have supported the work of our research and health partners for more than 140 years. Powered by responsible AI, ClinicalKey AI is a clinical decision support solution that delivers relevant insights at the point of care sourced from trusted, evidence-based content.
CuraScript SD by Evernorth
CuraScript SD provides integrated delivery solutions for the safe & efficient distribution of specialty pharmaceuticals & associated medical supplies. We’ve been caring for those who care for more than a quarter of a century by supplying biologics, branded drugs, generics, vaccines, infused medications and ancillary supportive care products to a wide range of medical providers.